Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Novo Nordisk A/S Common Stock (NY:NVO)

68.17 UNCHANGED
Streaming Delayed Price Updated: 7:00 PM EDT, May 22, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 42,847
Open 68.17
Bid (Size) 69.09 (2)
Ask (Size) 69.13 (2)
Prev. Close 68.17
Today's Range 68.17 - 68.17
52wk Range 57.00 - 148.15
Shares Outstanding N/A
Dividend Yield 3.22%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Hims & Hers Stock Drops After Evernorth Announces Cheaper Pricing For Weight-Loss Drugs: Retail’s Dull
Truist noted on Thursday that the $200/month price point is "highly attractive compared to other price points in the market," including Hims & Hers' compounded Semaglutide, Wegovy, and Liraglutide... 
Via Stocktwits
Novo Nordisk To Sell Wegovy For $199 A Month As Compounding Ban Nears: Retail’s Bullish
The offer will be valid through June 30 and aims to encourage patients who previously used compounded versions of the drug to move to Wegovy. 
Via Stocktwits
Exposures Product Safety

Performance

YTD
-22.1%
-22.1%
1 Month
+13.8%
+13.8%
3 Month
-18.6%
-18.6%
6 Month
-33.6%
-33.6%
1 Year
-49.1%
-49.1%

More News

Read More
Did Eli Lilly Just Say Checkmate to Novo Nordisk?
Via The Motley Fool
Wegovy, Zepbound Just Got Cheaper: Cigna Sets $200 Monthly Limit For Weight-Loss Drug Users
Via Stocktwits
Best Healthcare Stocks: Eli Lilly vs. Novo Nordisk
Via The Motley Fool
10 Health Care Stocks With Whale Alerts In Today's Session
Via Benzinga
Why Novo Nordisk Stock Popped on Tuesday
Via The Motley Fool
Exposures Product Safety
2 Fantastic Beaten-Down Growth Stocks Down 40% and 45% to Buy
Via The Motley Fool
The End Of The Diabetes Industry? This Small Cap Could Upend The Business Models of Pharma Giants
Via Benzinga
MarketBeat Week in Review – 05/12 - 05/16
Via MarketBeat
Topics Artificial Intelligence Economy Government
Exposures Artificial Intelligence Economy Interest Rates
NOVO-NORDISK A/S-SPONS ADR (NYSE:NVO) – A Strong Growth Stock with Technical Breakout Potential
Via Chartmill
On Holding on Fire
Via The Motley Fool
Topics Bonds Government
Exposures Debt Markets Political
3 Stocks That Will Profit From Trump's Drug Price Cut
Via Benzinga
Topics Government
Exposures Political
Why Novo Nordisk Stock Just Slipped
Via The Motley Fool
Novo Nordisk Sheds 4% After Ousting CEO As Eli Lilly Rivalry Slams Stock Price
Via Investor's Business Daily
Exposures Product Safety
Ozempic Maker Novo Nordisk Looks For New Chief, Jørgensen Steps Down From CEO Role
Via Benzinga
Novo Nordisk CEO Lars Jørgensen Steps Down Amid Challenges, Retail Chatter Spikes
Via Stocktwits
Wall Street Expects This Obesity Drug Stock to Skyrocket 35% Over the Next 12 Months
Via The Motley Fool
Is It Time to Buy the Dip in Novo Nordisk Stock?
Via MarketBeat
Topics Government
Exposures Political Product Safety
Novo Nordisk's Ozempic Weight Loss Jabs Could Boost UK Economy By $6 Billion, Study Finds
Via Benzinga
Topics Economy
Exposures Economy
Novo Nordisk Inks $2.2 Billion Deal With Septerna To Develop Oral Weight Loss And Diabetes Drugs
Via Benzinga
Novo Nordisk Inks A Major Obesity Deal, Sending Shares Of New Partner Septerna Skyrocketing
Via Investor's Business Daily
Novo Nordisk Inks $2.2B Deal With Septerna: Retail’s Thrilled
Via Stocktwits
Topics Artificial Intelligence
Exposures Artificial Intelligence
Why Weight-Loss Developer Stocks Tumbled on Tuesday
Via The Motley Fool
Topics Government
Exposures Political
Is the Fed on the Right Track?
Via The Motley Fool
Topics Economy World Trade
Exposures Interest Rates Tariff

Frequently Asked Questions

Is Novo Nordisk A/S Common Stock publicly traded?
Yes, Novo Nordisk A/S Common Stock is publicly traded.
What exchange does Novo Nordisk A/S Common Stock trade on?
Novo Nordisk A/S Common Stock trades on the New York Stock Exchange
What is the ticker symbol for Novo Nordisk A/S Common Stock?
The ticker symbol for Novo Nordisk A/S Common Stock is NVO on the New York Stock Exchange
What is the current price of Novo Nordisk A/S Common Stock?
The current price of Novo Nordisk A/S Common Stock is 68.17
When was Novo Nordisk A/S Common Stock last traded?
The last trade of Novo Nordisk A/S Common Stock was at 05/22/25 07:00 PM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.